Evidence map›Paper›PMID 37268424›Full record

ArticleJournal of nuclear medicine : official publication, Society of Nuclear Medicine2023

Optimized SPECT Imaging of

Lars Tore Gyland Mikalsen, Monika Kvassheim, Caroline Stokke

Abstract read
In one paragraph

Article in Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Normal Tissue Dosimetry of IntraperitonealJournal of nuclear medicine : official publication, Society of Nuclear Medicine · 2026
    Article
  2. Article
  3. Therapeutic evaluation of [European journal of nuclear medicine and molecular imaging · 2025
    Article
  4. DifferentToxics · 2025
    Article
  5. Article
  6. First-in-Human Phase 0 Study of AB001, a Prostate-Specific Membrane Antigen-TargetedJournal of nuclear medicine : official publication, Society of Nuclear Medicine · 2025
    Article
  7. Article
  8. Lead-it-EAZY! GMP-compliant production of [EJNMMI radiopharmacy and chemistry · 2024
    Article
  9. Review
  10. Influence of the Molar Activity ofPharmaceuticals (Basel, Switzerland) · 2023
    Article
  11. Imaging ofEJNMMI physics · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Lars Tore Gyland MikalsenDivision of Radiology and Nuclear Medicine, Oslo University Hospital, Oslo, Norway; ltmikals@ous-hf.no.
Monika KvassheimDivision of Radiology and Nuclear Medicine, Oslo University Hospital, Oslo, Norway.
Caroline StokkeDivision of Radiology and Nuclear Medicine, Oslo University Hospital, Oslo, Norway.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In preparation for an α-particle therapy trial using 1-7 MBq of

Indexed as

LeadThallium RadioisotopesImage Processing, Computer-AssistedMonte Carlo MethodPhantoms, ImagingPhotonsRadionuclide ImagingTomography, Emission-Computed, Single-PhotonLeadThallium RadioisotopesoptimizationPb212Ra224SPECTα-particle therapy

Identifiers

PMID37268424
PMCPMC10315694

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.